EXPONENT INC — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Exponent reported Q2 2026 revenues of $171.6M (21% YoY growth; 12% organic growth excluding reimbursements at $148.9M), with net income of $29.4M or $0.60 diluted EPS vs. $26.6M/$0.52 in Q2 2025. EBITDA was $42.7M (28.7% margin). For FY2026, the company raised guidance: revenues before reimbursements to grow 9–10% (vs. prior 8–9%) and EBITDA margin to 27.8–28.1% (vs. prior 27.5–28.0%). The Board also increased the stock repurchase authorization by $50M and declared a $0.31 quarterly dividend. Year-to-date H1 2026 revenues were $337.9M (18% growth) and net income $59.0M ($1.19 EPS). The company returned $177.4M to shareholders (H1: $31.3M dividends + $146.1M buybacks; LTM: $272M total).
Why this rating
Strong organic growth and margin expansion relative to size; guidance raise and dividend/buyback continuation reflect confidence but represent routine capital allocation for a $3B company.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.